MyChesCo on MSN9h
Cabaletta Bio Reports Strong Clinical Progress and Q4 2024 Financial Results
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced its financial results for the fourth quarter and full ...
MyChesCo on MSN13d
NCCN Launches Free On-Demand Webinar on Cancer Clinical Trials
The National Comprehensive Cancer Network® (NCCN®) has released a free, on-demand webinar titled “Why Should I Consider a ...
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials ...
PharmiWeb23d
AAVantgarde announces 2 presentations at ARVO 2025…
The oral presentation from the LUCE-1 clinical trial in Usher 1B builds on the data presented at the FLORetina medical conference in December 2024 with updates from more patients dosed since then, and ...
Morningstar13d
FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference
today announced that results from its Phase 2 FIGHT DMD clinical trial were selected for a late-breaking presentation at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference ...
Enid News & Eagle23d
AAVantgarde announces 2 presentations at ARVO 2025 annual meeting: LUCE-1 clinical trial data ...
The oral presentation from the LUCE-1 clinical trial in Usher 1B builds on the data presented at the FLORetina medical conference in December 2024 with updates from more patients dosed since then ...
Altis Labs Announces Presentation Of AI Model Evaluation On Data From Phase 3 Lung Cancer Trial At ELCC 2025
Altis's AI Model Outperforms RECIST 1.1 in Predicting Overall Survival These findings showcase IPRO-Δ's potential to accelerate clinical d ...